PhenMap tool could spare thousands of patients from treatment that would be ineffective for themA fresh artificial intelligence-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently introduced by the NHS has been announced.Researchers at London’s Institute of Cancer study and the RCSI University of Medicine and Health Sciences in Dublin have developed the method with the goal of sparing potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. Continue reading…
(This article was automatically generated from an AI news feed and rewritten for originality.)
